Home Cart Sign in  
Chemical Structure| 1336874-02-2 Chemical Structure| 1336874-02-2

Structure of 1336874-02-2

Chemical Structure| 1336874-02-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1336874-02-2 ]

CAS No. :1336874-02-2
Formula : C17H25NO7
M.W : 355.38
SMILES Code : O=C(C1CCN(C(OC(C)(C)C)=O)CC1)C2C(OC(C)(C)OC2=O)=O
MDL No. :MFCD23381615

Safety of [ 1336874-02-2 ]

Application In Synthesis of [ 1336874-02-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1336874-02-2 ]

[ 1336874-02-2 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 1240518-54-0 ]
  • [ 1336874-02-2 ]
  • tert-butyl 4-(10-cyano-2-oxo-1,2-dihydropyrimido[1,2-b]indazol-4-yl)piperidine-1-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
25% 3-Amino-lH-indazole-4-carbonitrile (0.51 g, 3.20 mmol) and tert-butyl 4-[(2,2-dimethyl-4,6-dioxo-l,3- dioxan-5-yl)carbonyl]piperidine-l -carboxylate (1.27 g, 3.55 mmol) were dissolved in acetonitrile (20 mL) and refluxed for 6 h. After cooling to RT, the solvent was removed in vacuo and the residue was dissolved in l-methoxy-2-propanol (20 mL). Potassium phosphate (1.37 g, 6.45 mmol) was added and the mixture was stirred at 80 C for 6 h. Concentration in vacuo and purification by preparative HPLC (Method 1A) afforded the title compound (0.32 g, 25% of theory). LC-MS (Method IB): Rt = 1.07 min, MS (ESIPos): m/z = 394 [M+H]+
25% 3-Amino-li7-indazole-4-carbonitrile (0.51 g, 3.20 mmol) and ieri-butyl 4-[(2,2-dimethyl-4,6-dioxo-l,3- dioxan-5-yl)carbonyl]piperidine-l-carboxylate (1.27 g, 3.55 mmol) were dissolved in acetonitrile (20 mL) and refluxed for 6 h. After cooling to RT, the solvent was removed in vacuo and the residue was dissolved in l-methoxy-2-propanol (20 mL). Potassium phosphate (1.37 g, 6.45 mmol) was added and the mixture was stirred at 80 C for 6 h. Concentration in vacuo and purification by preparative HPLC (Method 1A) afforded the title compound (0.32 g, 25% of theory). LC-MS (Method IB): Rt = 1.07 min, MS (ESIPos): m/z = 394 [M+H]+
0.32 g With potassium phosphate; In acetonitrile; for 6h;Reflux; Example 78A Tert-butyl 4-(10-cyano-2-oxo-1,2-dihydropyrimido[1,2-b]indazol-4-yl)piperidine-1-carboxylate 3-Amino-1H-indazole-4-carbonitrile (0.51 g, 3.20 mmol) and tert-butyl 4-[(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)carbonyl]piperidine-1-carboxylate (1.27 g, 3.55 mmol) were dissolved in acetonitrile (20 mL) and refluxed for 6 h. After cooling to RT, the solvent was removed in vacuo and the residue was dissolved in 1-methoxy-2-propanol (20 mL). Potassium phosphate (1.37 g, 6.45 mmol) was added and the mixture was stirred at 80 C. for 6 h. Concentration in vacuo and purification by preparative HPLC (Method 1A) afforded the title compound (0.32 g, 25% of theory). LC-MS (Method 1B): Rt=1.07 min, MS (ESIPos): m/z=394 [M+H]+
 

Historical Records

Technical Information

Categories